This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008; 49: 480-508. doi: 10.2967/jnumed.107.047787FletcherJWDjulbegovicBSoaresHPSiegelBALoweVJLymanGHet alRecommendations on the use of 18F-FDG PET in oncology20084948050810.2967/jnumed.107.04778718287273Open DOISearch in Google Scholar
Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19: 61-77; quiz 150-1. doi: 10.1148/radiographics.19.1.g99ja0761ShrevePDAnzaiYWahlRLPitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants1999196177quiz 150-110.1148/radiographics.19.1.g99ja07619925392Open DOISearch in Google Scholar
Rosenbaum SJ, Lind T, Antoch G, Bockisch A. False-positive FDG PET uptake-the role of PET/CT. Eur Radiol 2006; 16: 1054-65. doi: 10.1007/s00330-005-0088-yRosenbaumSJLindTAntochGBockischAFalse-positive FDG PET uptake-the role of PET/CT20061610546510.1007/s00330-005-0088-y16365730Open DOISearch in Google Scholar
Israel O, Yefremov N, Bar-Shalom R, Kagana O, Frenkel A, Keidar Z, et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med 2005; 46: 758-62.IsraelOYefremovNBar-ShalomRKaganaOFrenkelAKeidarZet alPET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance20054675862Search in Google Scholar
Lerman H, Metser U, Grisaru D, Fishman A, Lievshitz G, Even-Sapir E. Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and post-menopausal patients: assessment by PET/CT. J Nucl Med 2004; 45: 266-71.LermanHMetserUGrisaruDFishmanALievshitzGEven-SapirENormal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and post-menopausal patients: assessment by PET/CT20044526671Search in Google Scholar
Liu Y. Benign ovarian and endometrial uptake on FDG PET-CT: patterns and pitfalls. Ann Nucl Med 2009; 23: 107-12. doi: 10.1007/s12149-008-0227-zLiuYBenign ovarian and endometrial uptake on FDG PET-CT: patterns and pitfalls2009231071210.1007/s12149-008-0227-z19225932Open DOISearch in Google Scholar
Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996; 26: 308-14. doi: 10.1016/S0001-2998(96)80006-7CookGJFogelmanIMaiseyMNNormal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation1996263081410.1016/S0001-2998(96)80006-7Open DOISearch in Google Scholar
Nishizawa S, Inubushi M, Okada H. Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers. Eur J Nucl Med Mol Imaging 2005; 32: 549-56. doi: 10.1007/s00259-004-1703-xNishizawaSInubushiMOkadaHPhysiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers2005325495610.1007/s00259-004-1703-x15599527Open DOISearch in Google Scholar
Kim SK, Kang KW, Roh JW, Sim JS, Lee ES, Park SY. Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle. Eur J Nucl Med Mol Imaging 2005; 32: 757-63. doi: 10.1007/s00259-005-1771-6KimSKKangKWRohJWSimJSLeeESParkSYIncidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle2005327576310.1007/s00259-005-1771-615772859Open DOISearch in Google Scholar
Chiazze L, Jr., Brayer FT, Macisco JJ, Jr., Parker MP, Duffy BJ. The length and variability of the human menstrual cycle. JAMA 1968; 203: 377-80. doi: 10.1001/jama.1968.03140060001001ChiazzeLJrBrayerFTMaciscoJJJrParkerMPDuffyBJThe length and variability of the human menstrual cycle19682033778010.1001/jama.1968.03140060001001Open DOISearch in Google Scholar
Weir I. Spearman’s correlation. Statstutor, Mathematics Education Centre Loughborough University. 2016; 29. Available at: http://wwwstatstutoracuk/resources/uploaded/spearmanspdfAccessed.WeirIStatstutor Mathematics Education Centre Loughborough University201629Available athttp://wwwstatstutoracuk/resources/uploaded/spearmanspdfAccessedSearch in Google Scholar
Csapo AI, Pinto-Dantas CA. The effect of progesterone on the human uterus. Proc Natl Acad Sci U S A 1965; 54: 1069-76. doi: 10.1073/pnas.54.4.1069CsapoAIPinto-DantasCAThe effect of progesterone on the human uterus19655410697610.1073/pnas.54.4.10692197955219818Open DOISearch in Google Scholar
Widmaier EP, Raff H, Strang KT. Vander’s human physiology: the mechanisms of body functions. New York: McGraw-Hill Higher Education; 2008.WidmaierEPRaffHStrangKTNew YorkMcGraw-Hill Higher Education;2008Search in Google Scholar
De Geyter C, De Geyter M, Huber PR, Nieschlag E, Holzgreve W. Progesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex. Hum Reprod 2002; 17: 933-9. doi: 10.1093/humrep/17.4.933DeGeyter CDeGeyter MHuberPRNieschlagEHolzgreveWProgesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex200217933910.1093/humrep/17.4.93311925385Open DOISearch in Google Scholar
Van Iten B. Estrogen and the Menstrual Cycle in Humans. Embryo Project Encyclopedia 2016. Available at: https://embryo.asu.edu/pages/estrogen-and-menstrual-cycle-humansVanIten B2016Available athttps://embryo.asu.edu/pages/estrogen-and-menstrual-cycle-humansSearch in Google Scholar
Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev 2009; 30: 465-93. doi: 10.1210/er.2009-0006BroekmansFJSoulesMRFauserBCOvarian aging: mechanisms and clinical consequences2009304659310.1210/er.2009-000619589949Open DOISearch in Google Scholar
Kol S, Ben-Shlomo I, Ruutiainen K, Ando M, Davies-Hill TM, Rohan RM, et al. The midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3. Possible role for interleukin-1, a putative intermediary in the ovulatory process. J Clin Invest 1997; 99: 2274-83. doi: 10.1172/JCI119403KolSBen-ShlomoIRuutiainenKAndoMDavies-HillTMRohanRMet alThe midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3 Possible role for interleukin-1, a putative intermediary in the ovulatory process19979922748310.1172/JCI1194035080609151802Open DOISearch in Google Scholar
Balsara G, Hernandez E. The ovary: normal, physiologic changes, endometriosis, and metastatic tumors. Clinical Gynecologic Pathology. Philadelphia, PA: Saunders. 1995; 404-9.BalsaraGHernandezEPhiladelphia, PASaunders19954049Search in Google Scholar
Reed BG, Carr BR. The normal menstrual cycle and the control of ovulation. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, et al, editors. Endotext [Internet] South Dartmouth (MA): MDText.com Inc.; 2000.ReedBGCarrBRThe normal menstrual cycle and the control of ovulationInFeingoldKRAnawaltBBoyceAChrousosGDunganKGrossmanAet al, editorsSouth Dartmouth (MA)MDText.comInc2000Search in Google Scholar
Zhu Z, Wang B, Cheng W, Cheng X, Cui R, Huo L, et al. Endometrial and ovarian F-18 FDG uptake in serial PET studies and the value of delayed imaging for differentiation. Clin Nucl Med 2006; 31: 781-7. doi: 10.1097/01. rlu.0000247261.82757.eaZhuZWangBChengWChengXCuiRHuoLet alEndometrial and ovarian F-18 FDG uptake in serial PET studies and the value of delayed imaging for differentiation200631781710.1097/01. rlu.0000247261.82757.eaOpen DOISearch in Google Scholar